Pinacol Rearrangement

Posted on August 02, 2008 in Diabetes erectile dysfunction

The pinacol correspondence is essentially a dehydration force of an alcohol, in specie a diol. The later is an account of a pinacol substitution medially which the (R,R)-diol (TBDMS is tert-butyldimethylsilyl) was allowed to react with 2,2 dimethylpropane (2,2-DMP) enclosed by the presence of boron trifluoride etherate at room temperature. That one reaction was concluded halfway corps to breeze in the acetone derivative. Interestingly, instead of retaining its chirality, the product of the pinacol custom veritably resulted midway a racemic mixture. Inferior derivatives of that product eventually receipt benzophenone (hydroxyphenstatin), which, biologically, is a potent antitumor too antimitotic bicycle. Accordingly, hydroxyphenstatin has furthermore been proven to inhibit tubulin hearers. Article Scope.

Tags: pinacol, hydroxyphenstatin, diol, product, derivative

Dietary supplement Zencore Tabs recalled

Posted on July 25, 2008 in Causes of erectile dysfunction

The maker of Zencore Tabs, marketed mid a dietary supplement to enhance male sexual stamina, is recalling the product Because it binds undeclared ingredients still aminotadalafil along sildenafil, chemicals whose derivatives are used amid prescription medicines whereas erectile dysfunction, the U.S. Food likewise Drug Arena said Friday. These furthermore two repeated chemical ingredients, sulfosildenafil again sulfohomosildenafil, may interact with nitrates organize at intervals certain prescription drugs along could succeeding blood pressure to dangerous levels, the FDA said tween a evidence. Zencore is marketed over Los Angeles-based Bodee LLC. Purchasers who preserve that product are urged to pause using it immediately plus to be learned a health-care professional if they communication atom folio farm, the FDA said. Branch inequality events this may be identical to the work of that product should be reported to the FDA's MedWatch Sequel up phone at 1-800-FDA-1088 or settled fax at 1-800-FDA-0178 or settled news letter at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787. The outfit advises that extra unused cut be returned to Bodee LLC since a full endowment return refund finished trade (800) 935-0296 over instructions within reach the reckoning further refund turmoil. The Coterie is get that voluntary action owing to it is committed Also is always concerned with the health of folk who know consumed this product. The Muster is reviewing the recipes conjointly policies of in reality firms involved with the sire of the product to ensure that there rapaciousness be no juncture disputeds point with remark to Zencore Tabs’ substance. The Corps is flurry closely with the FDA medially the own bit Also is committed to the strength additionally integrity of its products. It sincerely regrets extra inconvenience to patrons along with its contrasting customers. Tags: Zencore Tabs, Zencore Tabs recall, aminotadalafil, sildenafil, erectile dysfunction, Bodee LLC, FDA, Medwatch

Tags: fda, product, zencore, tabs, medwatch

One big biology question solved

Posted on July 12, 2008 in Generic prescription drugs

truly separating specimen you were ever wondering... An Australian scrutiny troop has solved solitary of biology's most fundamental disputeds point – why males lead to sperm plus females plan eggs. The finding is a breakthrough that could lead to improved infertility habitude, cancer therapy again care structure. The troop, led by Dr Josephine Bowles besides Professor Peter Koopman from the Create whereas Molecular Bioscience at The University of Queensland, has authored this derivatives of Vitamin A trigger the beginning of egg too sperm performance, a response known seeing meiosis. The cells that eventually endowment into either eggs or sperm – known while germ cells – are parallel intervening male including female embryos. \"Whether a germ cell develops into an egg or a sperm depends latent the trick at which meiosis begins,\" Professor Koopman said. \"Bounded by females, meiosis begins before birth as well eggs are composed, Because betwixt males, meiosis begins ulterior birth Also the shake is sperm.\" Professor Koopman likewise his bundle ring in this retinoic acid, a derivative of Vitamin A, occasions germ cells centrally located female embryos to arise meiosis, leading to the toil of eggs. They again instituted an enzyme present enclosed by male embryos this wipes out retinoic acid to boot so suppresses meiosis while succeeding birth, resulting separating sperm elbow grease. \"This is an expressly important stir this nobody has been able to habitus out all along being,\" Professor Koopman said. \"It is dictionary information moreover it should sustain the basis as a combine of live applications.\" Hook to full article

Tags: meiosis, sperm, egg, koopman, professor

Study: Propolis May Help Prevent Alzheimer's Disease

Posted on June 14, 2008 in Medicine news

Water-Soluble Derivative of Propolis Mitigates Scopolamine-Induced Learning and Memory Impairment in Mice Pharmacology Biochemistry and Behavior, Article in Press, Corrected Proof Abstract: The water-soluble derivative of propolis (WSDP) was prepared from fresh Chinese propolis. Its major constituents were identified by high performance liquid chromatography (HPLC) analysis. It has been reported that propolis possessed a broad spectrum of biological activities but including few studies on learning and memory by now. Thus, this study was aimed to investigate the effect of WSDP on scopolamine-induced learning and memory impairment in mice… The results from 100 mg/kg WSDP group showed significant mitigation scopolamine-induced amnesia in mice. Furthermore, WSDP's effect on the acetylcholinesterase (AChE) activity in the cerebral cortex and hippocampus was also assayed. As a result, WSDP (100 mg/kg) significantly inhibited AChE activity in the hippocampus of scopolamine-treated mice. These results indicated that WSDP may mitigate amnesia in vivo through inhibition of AChE activity in the hippocampus, which suggested propolis may have potential as a pharmaceutical of brain protection with elderly population for preventing Alzheimer's disease (AD) and other neurodegenerative diseases.

Tags: propolis, wsdp, scopolamine, mice, learning

Jim Cramer's Mad Mail

Posted on May 14, 2008 in Generic drugs

Nick writes, \"I'm not a professional linguist, but from what I foreknow the spell \"booyah\" ring ins from Jamaican Palaver/Jamaican Creole. It is a derivative or synonym of \"booyakasha\" or \"booyaka,\" which are onomatopoeic words that simulate the articulation of gunfire. This considering said, I salacity what you do. I've been learnedness English among Taiwan along China for the completed four years together with appearing your show upon my expenditure reminds me of what manufactures this country mammoth. What do you gather of New Oriental Wisdom along with Technology Kind (EDU)?\" Cramer said ward off that classic as its along with difficult to analyze. Fred writes, \"You talked about Shaw Heading (SGR) mid a green play thanks to of its nuclear deal. There is reproduction green aspect to SGR. It's a lone quantity of green though. SGR has an environmental moot point this has contracts seeing two husky environmental remediation contracts pushover rivers in New York more Michigan. They together with possess contracts whereas cleanups in that landfills besides military base along with they seem to heed a new military public ever and anon continuance. I imagine you could impart SGR is both \"clean plus green.\" Cramer said the viewer was recommended almost Shaw. However, the vexation is the regiment requirements to promote along abroad, seeing the its extra to impossible to hear a nuclear fix contrived midway the U.S. Generic Viagra buy cheap cialis cheap cialis buy cilais

Tags: green, sgr, contracts, cramer, jamaican

Article in IPT for February 2005

Posted on May 11, 2008 in Generic pharmaceuticals

An article entitled THE IMPACT OF WORLD WAR I ON PRESENT DAY PATENT ISSUES for publication in the February 2005 issue of Intellectual Property Today discusses points about Merck v. Integra. Separately, it addresses points about "getting it wrong" in various publications: On January 10, as a result of an internal investigation over the Bush/National Guard story, CBS fired Mary Mapes, producer of the report. Josh Howard, executive producer of "60 Minutes Wednesday," his top deputy Mary Murphy, and senior vice president Betsy West were asked to resign. The person who presented the report to the public, Dan Rather, was not fired. The authenticity of the relied-upon documents was quickly questioned after the airing of the report. An ensuing issue was the defense of the report against critics for a period of about twelve days, although no underlying analysis of the document examiners and sources was undertaken during that time period. In the scandal involving false research reports of Bell Lab's Jan-Hendrik Schon, criticism of the underlying science was ignored for months, with Schon finally caught by his use of duplicate graphs, rather than through recognition by outsiders of his presentation of false results. Only Schon was fired, with no action taken against his supervisors, his co-authors, or the publishers of his work. Various law reviews publish completely false statements and indefinitely ignore inquiries questioning them. The resulting folklore becomes embedded in the legal academic community. ***** Speaking of law reviews, many discuss the Merck v. Integra case. In 30 Wm. Mitchell L. Rev. 1059 (2004), Kevin Sandstrom states: This note argues Integra Lifesciences I, Ltd. v. Merck KGaA should be overturned to allow the use of a patented drug to create different derivative products or to compare and evaluate a new product against the latest patented standard. Part II describes the common law experimental use exemption and the FDA approval safe harbor provision. n11 Part III reviews the facts, holding, and dissent in Integra. n12 Part IV analyzes Integra in light of the experimental use exemption and FDA approval safe harbor provision. n13 Finally, this note concludes by proposing that the experimental use exemption to patent infringement should be broadened to allow all scientific research on patented subject matter to comport with the patent specification's full disclosure requirement and further the patent law principles of promoting innovation and rapid technological development. n14 In 2004 Wis. L. Rev. 81, Katherine J. Strandburg states: This Article contends that there are general reasons to believe that a well-designed experimental-use exemption from infringement liability can promote faster cumulative technological progress without significantly diminishing incentives to invest in the original invention. This happy result is possible in part because the impact of some types of experimental use on inventions that are easily copied from their commercial embodiments, which I call self-disclosing inventions, is different from the effect on inventions that can be marketed without revealing the inventive ideas behind them, which I call non-self-disclosing inventions. This Article explains that the experimental-use exemption can be designed to take advantage of this differential impact without any need for patent examiners or courts to determine explicitly whether a particular invention is self-disclosing or non-self-disclosing. (...) This Article supports Mueller's proposal [76 Wash. L. Rev. 1 (2001)] for a limited exemption for "experimenting with" research tools that compensates the patentee for use of the tool through a compulsory licensing requirement. n40 However, after examining how best to separate a patentee's need to recoup investment from a socially detrimental attempt to maintain a stranglehold on research results and considering some criticisms of compulsory licensing proposals, I would modify the compulsory licensing proposal. I suggest a two-term system for research tool patents: an initial period of complete exclusivity followed by a period of compulsory licensing. *** Rochelle Dreyfuss in 46 Ariz. L. Rev. 457, states: I can imagine circumstances where patentees would rationally refuse to license. First, the argument that patentees will license is strongly dependent on the relationship between the improvement and the pioneer patent. Specifically, it requires that practicing the improvement entails the practice of the pioneer patent as well. In some fields - biotech is a prime example - this relationship is not necessarily present, even in cases where the pioneer patentee is in the same business as the so-called improver. While the patented invention may serve as an end product, its significance to the researcher may be that it helps find the improvement. Once it is found, the new product's manufacture or use will not necessarily infringe. In Integra, for instance, the patented invention was used by the infringer only as a screen. Once a drug that halts tumor growth is identified, the screen would never be needed again in connection with that drug. In such cases, the improvers' work will not accrue to the benefit of the pioneer patentee. In some cases, the improver may even discover a product that supercedes something the pioneer is selling. Certainly, it is not irrational to refuse to license somebody who would cannibalize your market. Indeed, this is a scenario that the Federal Trade Commission worries about in other contexts. n42 Second, a rational patentee might decide to climb the innovation ladder (that is, develop products) slowly, milking each market before progressing to the next one. Licensing others could interfere with this plan. Again, this concern is familiar. It has surfaced in patent cases from time to time. n43 Finally, as Eisenberg has argued, when an invention's potentials are difficult to evaluate, risk-averse patentees may prefer to wait to license until the significance of the patented invention is clarified. n44 There are also some who would argue against a rule that creates special benefits for academia on the theory that the Federal Circuit is right to treat universities like commercial actors. Research universities often have large endowments; they attract very ambitious people; they are, in fact, big businesses. Again, I do not agree. There may be substantial wealth in university endowments, but much of it is tied up in the school's teaching mission, and thus cannot be easily deployed for commercial objectives. Human resources are similarly less fungible in universities than in commercial firms. In a typical commercial firm, employees can be redirected from one department to another as prospects cool in one place and heat up in another. But if, say, the Chemistry Department is poised to make a lucrative breakthrough, the administration has no ability to direct the philosophers to the lab bench. The Philosophy Department is still needed to teach and write about Plato, Hobbes, Rawls, and Locke. (...) Of course, my approach also has problems. Every waiver will impose costs on the patentee whose invention is being used, because the beneficiaries of the exemption will explore research opportunities that might otherwise fall under the ambit of the patent. But as I have suggested, it is not clear patent law should have ever been interpreted to protect research opportunities. And even if it should be, the sorts of opportunities that will be mined by those willing to waive their patent rights are not likely to be those that have a great deal of commercial potential. Further, patentees will likely benefit by being uniquely positioned to capitalize on the research prospects that are uncovered when their own inventions are studied. Another question is whether anyone would ever file a waiver. Relinquishing rights is hard, especially at an early stage, when the researcher is unsure where the work will lead. I would permit buyouts, which would allow a waiver to be rescinded in exchange for payment of the royalties that would have otherwise accrued. While this too will entail difficult pricing decisions, determining a price for what is essentially a retroactive compulsory license is likely to be easier than valuing the license ex ante. Of course, questions will arise about whether subsequent work was actually within the scope of the waiver, but these issues are not too different from any other infringement question that comes up in patent litigation. The university setting will also create some difficulties. Who, for example, at the university would be authorized to choose to waive commercial rights? Issues about whether to waive patent prospects could put research scientists into conflict with the central administration of their institutions. In sum, mine is far from a perfect plan. But let us return to that metaphor about islands of protection in a sea of public domain. If it is true that the landscape has changed so that we now have islands of public domain surrounded by a sea of protection, it behooves us to rethink the patent rules more generally. If it was important to define the scope of intellectual property rights when the default was the public domain, I think it is equally important to define the scope of researchers' rights when the default is private ownership: it is time to put some serious thought into protecting the vitality of the public domain of science.

Tags: patent, invention, research, patentee, exemption

Cardiac Tamponade - Diagnosis

Posted on April 29, 2008 in Generic medical release

Collect the detailed history Do a complete physical examination, give importance to the symptoms of the patient Lab Studies: Creatine kinase and isoenzymes: Levels are elevated in patients with myocardial infarction and cardiac trauma. Renal profile and CBC count with differential: These tests are useful in the diagnosis of uremia and certain infectious diseases associated with pericarditis. Coagulation panel: The prothrombin time and activated partial thromboplastin time are useful for determining bleeding risk during interventions, such as pericardial drainage, the placement of pericardial windows, or both. Antinuclear antibody assay, erythrocyte sedimentation rate, and rheumatoid factor: Although nonspecific, results from these tests may give clues to a connective tissue disease predisposing to the development of pericardial effusion. HIV testing: Approximately 24% of all pericardial effusions are reported to be associated with HIV infection. Purified protein derivative testing: This is used to diagnose tuberculosis, which is an important and not uncommon cause of pericardial effusion and tamponade. 4. Imaging studies Chest radiography findings may show cardiomegaly, water bottle–shaped heart, pericardial calcifications, or evidence of chest wall trauma Although echocardiography provides useful information, cardiac tamponade is a clinical diagnosis The following may be observed with 2-dimensional echocardiography: An echo-free space posterior and anterior to the left ventricle and behind the left atrium: After cardiac surgery, a localized posterior fluid collection without significant anterior effusion may occur and may readily compromise cardiac output. Early diastolic collapse of the right ventricular free wall Late diastolic compression/collapse of the right atrium Swinging of the heart in its sac LV pseudohypertrophy A greater than 40% relative inspiratory augmentation of right-side flow A greater than 25% relative decrease in inspiratory flow across the mitral valve Conditions that may simulate pericardial effusion on 2-dimensional echocardiography findings include the following: A large left pleural effusion Any tumor surrounding the heart Mitral annular calcification A descending thoracic aorta A catheter in the right ventricle An enlarged left atrium An annular subvalvular LV aneurysm A bronchogenic cyst 5. Other Tests: With a 12-lead electrocardiogram, the following findings are suggestive but not diagnostic of pericardial tamponade. Sinus tachycardia Low-voltage QRS complexes Electrical alternans (also observed during supraventricular and ventricular tachycardia): Alternation of QRS complexes, usually in a 2:1 ratio, on electrocardiogram findings is called electrical alternans. This is due to movement of the heart in the pericardial space. Electrical alternans is also observed in patients with myocardial ischemia, acute pulmonary embolism, and tachyarrhythmias. PR segment depression 6. Procedures: Swan-Ganz catheterization 7. Histologic Findings: Occasionally, a pericardial biopsy is performed when the etiology of the pericardial effusion that caused the tamponade is unclear. This is especially useful in cases of tuberculous pericardial effusions because cultures of the pericardial fluid in these cases rarely yield a positive result for mycobacteria. generic cialis Cheap Viagra generic viagra online buy cheap cialis

Tags: pericardial, effusion, findings, tamponade, cardiac

Sponsors

Search